𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon alfa subtypes and levels of type I interferons in the liver and peripheral mononuclear cells in patients with chronic hepatitis C and controls

✍ Scribed by Yurdana Castelruiz; Esther Larrea; Patricia Boya; María-Pilar Civeira; Prof. Jesús Prieto

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
75 KB
Volume
29
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis C virus RNA in plasma and bloo
Hepatitis C virus RNA in plasma and blood mononuclear cells in patients with chronic hepatitis C treated with alpha-interferon
✍ A. Ounanian; J. M. Seigneurin; N. Gueddah; A. Rolachon; M. A. Thelu; J. P. Zarsk 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 489 KB 👁 2 views

## Abstract Hepatitis C virus (HCV), a positive stranded RNA virus, is the main causative agent of post‐transfusion and sporadic non‐A non‐B hepatitis worldwide. Paired samples of plasma and peripheral blood mononuclear cells (PBMC) from 11 patients with chronic hepatitis C treated with α‐interfero

Quantitation of hepatitis C virus in liv
Quantitation of hepatitis C virus in liver and peripheral blood mononuclear cells from patients with chronic hepatitis C virus infection
✍ Martín, Julio; Navas, Sonia; Quiroga, Juan Antonio; Colucci, Giuseppe; Pardo, Ma 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

Since the natural history of hepatitis C virusassociated liver disease and the therapeutic responsiveness might vary according to liver and blood mononuclear cells viral levels, it may be important to quantitate viral RNA in liver, blood mononuclear cells and serum, and to compare these data with ge

Serum levels of hepatitis C virus core p
Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa
✍ E Tanaka; K Kiyosawa; A Matsumoto; T Kashiwakuma; A Hasegawa; H Mori; O Yanagiha 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

The quantitation of hepatitis C virus (HCV) viremia RNA is measured by molecular techniques such as comcan be helpful in the diagnosis, therapy, and monitoring petitive reverse-transcription polymerase chain reacof patients with chronic hepatitis C. A sensitive and tion and branched DNA (bDNA) signa

Sequential versus concomitant administra
Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: Results of a randomized, controlled trial
✍ Raffaello Sostegni; Valeria Ghisetti; Fabrizia Pittaluga; Giovanna Marchiaro; Gi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

We conducted a three-arm, randomized trial in 96 patients with chronic hepatitis C who did not respond to interferon alfa to compare treatments. Group 1 (33 patients) received ribavirin alone (1,000 mg/daily for 6 months) followed by interferon alfa n-3 alone (3 MU thrice weekly for 6 months); group

Relationship of the genomic complexity o
Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b interferon
✍ Francesc-Xavier López-Labrador; Sergi Ampurdanès; Mireia Giménez-Barcons; Magdal 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 3 views

In patients with chronic hepatitis C, the influence of the genetic heterogeneity of the hepatitis C virus (HCV) on the progression of liver disease and on the responsiveness to interferon therapy is a matter of controversy. In this study we evaluated the genetic complexity of HCV by singlestrand con